| Completed | Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome NCT07460908 | Lahore General Hospital | N/A |
| Recruiting | Initial Resuscitation for Acute Kidney Injury in Cirrhosis NCT06525623 | Massachusetts General Hospital | N/A |
| Active Not Recruiting | Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome NCT06256432 | Noorik Biopharmaceuticals AG | Phase 2 |
| Terminated | NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirr NCT06000748 | University of California, San Francisco | Phase 2 / Phase 3 |
| Unknown | Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome NCT05875948 | River 2 Renal Corp. | Phase 2 |
| Recruiting | A Retrospective Analysis of Outcomes in Patients with Hepatorenal Syndrome At Methodist Dallas Medical Center NCT06095440 | Methodist Health System | — |
| Recruiting | HRS-AKI Treatment With TIPS in Patients With Cirrhosis NCT05346393 | Jena University Hospital | N/A |
| Completed | International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project NCT05387811 | Azienda Ospedaliera di Padova | — |
| Suspended | The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I NCT04898010 | Lenar Yessayan | N/A |
| Completed | A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney NCT05309200 | Ocelot Bio, Inc | Phase 2 |
| Unknown | Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in C NCT05434286 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Withdrawn | Angiotensin 2 for Hepatorenal Syndrome NCT04048707 | University of California, Los Angeles | Phase 2 |
| Completed | Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE) NCT04460560 | University of Pennsylvania | Phase 3 |
| Completed | Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-o NCT04416282 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Korean Cohort Study of AKI & HRS in Cirrhosis NCT03530761 | Soonchunhyang University Hospital | — |
| Completed | Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 NCT02770716 | Mallinckrodt | Phase 3 |
| Withdrawn | Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure NCT01587222 | Anna Cruceta | Phase 2 |
| Unknown | The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressur NCT02489864 | Sun Yat-sen University | Phase 4 |
| Completed | Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pres NCT02789150 | University of Louisville | EARLY_Phase 1 |
| Terminated | Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline NCT02123576 | Patrick Northup, MD | N/A |
| Completed | Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury NCT02097784 | Hospices Civils de Lyon | N/A |
| Unknown | Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis NCT02049125 | University of Sao Paulo | — |
| Completed | Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis NCT01932151 | Hospital Clinic of Barcelona | N/A |
| Withdrawn | To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Synd NCT01649037 | Institute of Liver and Biliary Sciences, India | N/A |
| Recruiting | Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Pat NCT02434445 | The University of Hong Kong | — |
| Completed | Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients NCT01436500 | Cumberland Pharmaceuticals | Phase 2 |
| Completed | A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipres NCT01143246 | Mallinckrodt | Phase 3 |
| Completed | Single Pass Albumin Dialysis in Patients With Cirrhosis NCT00764049 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Completed | Noradrenalin vs Terlipressin in Hepatorenal Syndrome NCT00370253 | University of Turin, Italy | Phase 3 |
| Terminated | Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome NCT00734136 | Lahey Clinic | N/A |
| Terminated | Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome NCT00742339 | University of Padova | Phase 2 / Phase 3 |
| Completed | Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1 NCT00089570 | Mallinckrodt | Phase 3 |
| Suspended | Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin NCT00287664 | Hospital Clinic of Barcelona | Phase 4 |
| Completed | Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis NCT00359853 | Hospital Clinic of Barcelona | Phase 4 |